Literature DB >> 20470885

HDAC-mediated control of ERK- and PI3K-dependent TGF-β-induced extracellular matrix-regulating genes.

Matt J Barter1, Leon Pybus, Gary J Litherland, Andrew D Rowan, Ian M Clark, Dylan R Edwards, Tim E Cawston, David A Young.   

Abstract

Histone deacetylases (HDACs) regulate the acetylation of histones in the control of gene expression. Many non-histone proteins are also targeted for acetylation, including TGF-β signalling pathway components such as Smad2, Smad3 and Smad7. Our studies in mouse C3H10T1/2 fibroblasts suggested that a number of TGF-β-induced genes that regulate matrix turnover are selectively regulated by HDACs. Blockade of HDAC activity with trichostatin A (TSA) abrogated the induction of a disintegrin and metalloproteinase 12 (Adam12) and tissue inhibitor of metalloproteinases-1 (Timp-1) genes by TGF-β, whereas plasminogen activator inhibitor-1 (Pai-1) expression was unaffected. Analysis of the activation of cell signalling pathways demonstrated that TGF-β induced robust ERK and PI3K activation with delayed kinetics compared to the phosphorylation of Smads. The TGF-β induction of Adam12 and Timp-1 was dependent on such non-Smad signalling pathways and, importantly, HDAC inhibitors completely blocked their activation without affecting Smad signalling. Analysis of TGF-β-induced Adam12 and Timp-1 expression and ERK/PI3K signalling in the presence of semi-selective HDAC inhibitors valproic acid, MS-275 and apicidin implicated a role for class I HDACs. Furthermore, depletion of HDAC3 by RNA interference significantly down-regulated TGF-β-induced Adam12 and Timp-1 expression without modulating Pai-1 expression. Correlating with the effect of HDAC inhibitors, depletion of HDAC3 also blocked the activation of ERK and PI3K by TGF-β. Collectively, these data confirm that HDACs, and in particular HDAC3, are required for activation of the ERK and PI3K signalling pathways by TGF-β and for the subsequent gene induction dependent on these signalling pathways.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20470885     DOI: 10.1016/j.matbio.2010.05.002

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  35 in total

1.  Metalloprotease-disintegrin ADAM12 expression is regulated by Notch signaling via microRNA-29.

Authors:  Hui Li; Emilia Solomon; Sara Duhachek Muggy; Danqiong Sun; Anna Zolkiewska
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

Review 2.  Multiple roles of class I HDACs in proliferation, differentiation, and development.

Authors:  Nina Reichert; Mohamed-Amin Choukrallah; Patrick Matthias
Journal:  Cell Mol Life Sci       Date:  2012-07       Impact factor: 9.261

3.  Histone deacetylase 6 promotes growth of glioblastoma through inhibition of SMAD2 signaling.

Authors:  Shun Li; Xiao Liu; Xiangrong Chen; Liu Zhang; Xiangyu Wang
Journal:  Tumour Biol       Date:  2015-07-07

Review 4.  Targeting cardiac fibroblasts to treat fibrosis of the heart: focus on HDACs.

Authors:  Katherine B Schuetze; Timothy A McKinsey; Carlin S Long
Journal:  J Mol Cell Cardiol       Date:  2014-03-11       Impact factor: 5.000

5.  Association of histone acetylation at the ACTA2 promoter region with epithelial mesenchymal transition of lens epithelial cells.

Authors:  D A Ganatra; S Rajkumar; A R Patel; D U Gajjar; K Johar; A I Arora; F B Kayastha; A R Vasavada
Journal:  Eye (Lond)       Date:  2015-03-20       Impact factor: 3.775

6.  Inhibition of HDAC3 prevents diabetic cardiomyopathy in OVE26 mice via epigenetic regulation of DUSP5-ERK1/2 pathway.

Authors:  Zheng Xu; Qian Tong; Zhiguo Zhang; Shudong Wang; Yang Zheng; Qiuju Liu; Ling-Bo Qian; Shao-Yu Chen; Jian Sun; Lu Cai
Journal:  Clin Sci (Lond)       Date:  2017-07-05       Impact factor: 6.124

7.  Preclinical validation of AR42, a novel histone deacetylase inhibitor, as treatment for vestibular schwannomas.

Authors:  Abraham Jacob; Janet Oblinger; Matthew L Bush; Victoria Brendel; Griffin Santarelli; Abhik R Chaudhury; Samuel Kulp; Krista M D La Perle; Ching-Shih Chen; Long-Sheng Chang; D Bradley Welling
Journal:  Laryngoscope       Date:  2011-11-22       Impact factor: 3.325

8.  Hyaluronic acid promotes angiogenesis by inducing RHAMM-TGFβ receptor interaction via CD44-PKCδ.

Authors:  Deokbum Park; Youngmi Kim; Hyunah Kim; Kyungjong Kim; Yun-Sil Lee; Jongseon Choe; Jang-Hee Hahn; Hansoo Lee; Jongwook Jeon; Chulhee Choi; Young-Myeong Kim; Dooil Jeoung
Journal:  Mol Cells       Date:  2012-05-18       Impact factor: 5.034

Review 9.  Targeting inflammation in heart failure with histone deacetylase inhibitors.

Authors:  Timothy A McKinsey
Journal:  Mol Med       Date:  2011-01-20       Impact factor: 6.354

Review 10.  HDAC-dependent ventricular remodeling.

Authors:  Min Xie; Joseph A Hill
Journal:  Trends Cardiovasc Med       Date:  2013-03-15       Impact factor: 6.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.